MedPath

Study of Dermatonics Heel Balm compared to Moisturex cream for the Reduction/Removal of Hard Callused Plantar skin

Not yet recruiting
Conditions
Corns and callosities,
Registration Number
CTRI/2022/09/045825
Lead Sponsor
Dr Anjeeta Dhawan
Brief Summary

The study is a prospective, observational, single-center, two-arm, open label, pilot study to determine the efficacy and safety of investigational products for the reduction or removal of hard callused plantar skin. Participants will be selected as per the inclusion criteria. Participants will be asked not to use any additional moisturizing foot products on their feet or have any procedure done on their feet including pedicure. Participants will be instructed to use the products as suggested by the Investigator. Product (Dermatonics) will be applied on Left foot and Comparator (Moisturex) will be applied on Right Foot of each participant

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
All
Target Recruitment
10
Inclusion Criteria
  • Diabetic patients with dry and callused skin (Grading –1-5).
  • Subjects who are healthy with no significant concurrent illnesses or skin disease.
  • Subjects with visibly dry and rough skin on their heels.
  • Participants who will be able to provide written informed consent prior to the performance of any study specific procedures.
  • Female participants of child-bearing potential with negative serum pregnancy test at screening and negative urine pregnancy test at the time of screening.
  • Participants who are willing and able to comply with all study assessments and adhere to the protocol schedule.
Exclusion Criteria
  • Pregnant or lactating females or females of reproductive age not using a reliable form of contraception.
  • Subjects who take any medication likely to interfere with the study.
  • Subjects with a history of significant skin disease (e.g. eczema, psoriasis) 4.
  • Subjects with an allergy likely to interfere with the study.
  • Subjects who are unwilling or unable to give written consent.
  • Patients involved in clinical trials and taken Investigational drugs within 30 days of enrolment.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Analysis of reduction in the callus on the basis of assessment scaleday 0, 1st and 3rd
with detailed photographs having following Grades-day 0, 1st and 3rd
➢ Grade 0: smooth, fine lines, and no drynessday 0, 1st and 3rd
➢ Grade 1: dry lines, slight scaling, and skin thickeningday 0, 1st and 3rd
➢ Grade 2: small fissures, moderate scaling, and skin thickeningday 0, 1st and 3rd
➢ Grade 3: deep fissures, obvious scaling, and skin thickeningday 0, 1st and 3rd
➢ Grade 4: small gaps on fissures, severe scaling, and skinday 0, 1st and 3rd
thickening.day 0, 1st and 3rd
➢ Grade 5: Big gaps and Opening on Fissures, bleeding, extremeday 0, 1st and 3rd
scaling and skin thickening.day 0, 1st and 3rd
Improvement in Hydration based on “The Young Townson Footday 0, 1st and 3rd
skin hydration scaleâ€. Graded as:day 0, 1st and 3rd
Level 1: Well hydrated heels, with little or no signs of drying,day 0, 1st and 3rd
Level 2: Drying skin but no callus,day 0, 1st and 3rd
Level 3: Drying skin combined with callus,day 0, 1st and 3rd
Level 4: Callused skin with open slits.day 0, 1st and 3rd
Secondary Outcome Measures
NameTimeMethod
Improvement in General skin condition, skin colour and cracks.Any discoloration or hyperpigmentation and change in cracks on

Trial Locations

Locations (1)

Aashrya Eye, Skin and Dental Clinic

🇮🇳

West, DELHI, India

Aashrya Eye, Skin and Dental Clinic
🇮🇳West, DELHI, India
Dr Anjeeta Dhawan
Principal investigator
9810631823
anjeetadr@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.